抑制血小板吞噬作为小鼠免疫性血小板减少症中红细胞抗体治疗潜力的体外预测指标
研究检测了12种不同特异性和亚型的小鼠红细胞特异性抗体,其中8种可在抗原阳性小鼠中诱导贫血,仅5种改善免疫性血小板减少症(ITP)。体外支持红细胞吞噬的抗体均能在体内改善ITP,体外抑制血小板吞噬的抗体也均能改善ITP。结论认为诱导贫血不是改善ITP的充分条件,而抗体体外阻止血小板吞噬的能力可预测其改善ITP的能力。
要点
- 12种小鼠红细胞抗体中8种可诱导贫血,仅5种改善ITP。
- 体外支持红细胞吞噬的抗体均能在体内改善ITP。
- 体外抑制血小板吞噬的抗体也均能改善ITP。
核心结论
- 诱导贫血不是改善ITP的充分条件,但抗体体外阻止血小板吞噬的能力可预测其改善ITP的能力。
- 作者建议体外抑制血小板吞噬可能有助于判断红细胞抗体是否可能成为ITP临床候选药物。
研究设计与样本
- 研究检测了12种不同特异性和亚型的小鼠红细胞特异性抗体,并在抗原阳性小鼠中评估贫血诱导和ITP改善情况。
- 所有抗体均检测了体外支持巨噬细胞介导的红细胞吞噬的能力。
- 将抗体用于体外致敏红细胞后加入血小板吞噬试验,以检测各抗体抑制血小板吞噬的能力。
主要发现
- 12种抗体中8种可在抗原阳性小鼠中诱导贫血,其中仅5种改善ITP。
- 体外支持红细胞吞噬的抗体均能在体内成功改善ITP。
- 体外抑制血小板吞噬的抗体也均能在体内改善ITP。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polyclonal anti-D is a first-line therapy for immune thrombocytopenia (ITP). Monoclonal antibodies are desirable alternatives, but none have yet proven successful despite their ability to opsonize erythrocytes (or red blood cells, RBCs) and cause anemia. Here, we examined 12 murine erythrocyte-specific antibodies of different specificity and subtypes and found that 8 of these antibodies could induce anemia in antigen-positive mice. Of these 8 antibodies, only 5 ameliorated ITP. All antibodies were examined for their in vitro ability to support macrophage-mediated phagocytosis of erythrocytes. Antibodies which supported erythrocyte phagocytosis in vitro successfully ameliorated ITP in vivo. To examine the ability of each antibody to inhibit phagocytosis of platelets, the antibodies were used to sensitize erythrocytes in vitro and these were added to a platelet phagocytosis assay. Antibodies that inhibited platelet phagocytosis in vitro also all ameliorated ITP in vivo. We conclude that inducing anemia is not a sufficient condition for amelioration of ITP but that the antibody's ability to prevent platelet phagocytosis in vitro predicted its ability to ameliorate ITP. We suggest that inhibition of in vitro platelet phagocytosis may prove to be a valuable tool for determining which erythrocyte antibodies would likely be candidates for clinical use in ITP.
引用
- Khan R, Menard M, Jen CC, et al. Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP. Blood. 2020. PMID: 32374819. doi:10.1182/blood.2019003646
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。